NIH Building Infrastructure Leading to Diversity (BUILD) Initiative (U54)
The summary for the NIH Building Infrastructure Leading to Diversity (BUILD) Initiative (U54) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
NIH Building Infrastructure Leading to Diversity (BUILD) Initiative (U54): The NIH encourages institutions that seek to engage undergraduate students in innovative mentored research training programs to submit applications for cooperative agreement awards through the NIH Building Infrastructure Leading to Diversity (BUILD) initiative, one of three new Common Fund initiatives that together aim to enhance diversity in the biomedical, behavioral, clinical, and social sciences research workforce. Addressing a major leakage point in the research workforce pipeline, BUILD awards are intended to support the design and implementation of innovative programs, strategies and approaches to transform undergraduate research training and mentorship. BUILD awards will also support institutional and faculty development to further strengthen undergraduate research training environments.
Federal Grant Title: | NIH Building Infrastructure Leading to Diversity (BUILD) Initiative (U54) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-RM-13-016 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.310 |
CFDA Descriptions: | Trans-NIH Research Support |
Current Application Deadline: | Mar 18, 2014 |
Original Application Deadline: | Mar 18, 2014 |
Posted Date: | Dec 19, 2013 |
Creation Date: | Dec 19, 2013 |
Archive Date: | Apr 18, 2014 |
Total Program Funding: | $30,000,000 |
Maximum Federal Grant Award: | $3,000,000 |
Minimum Federal Grant Award: | none |
Expected Number of Awards: | 10 |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Private institutions of higher education
Public and State controlled institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification) - Additional Information on Eligibility
- Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-13-016.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
National Institutes of Health 301-496-3405 - Similar Government Grants
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
- • NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
- • NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
- • NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
- • Using Metabolomics to Investigate Biological Pathways and Networks (R01)
- • Assay Development for High Throughput Molecular Screening (R21)
- • Membrane Protein Production and Structure Determination (R01)
- More Grants from the National Institutes of Health
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)